FGA and coronary artery disorder: The cell death network was predicted to be more responsive to SNO modification level of proteins (ANXA1, FGA, FLNA, GSTP1, HBB, MTPN, PRDX6, THBS1, VCL, YY1) in clinically symptomatic patients as compared to the clinically asymptomatic ChD subjects (p = 8.71E-03, Figure 7C).